Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home / News

17.01.2011

Russia’s pharma cos can create new generation medicines - Medvedev

Russian President Dmitry Medvedev has expressed confidence that the country’s pharmaceutical companies will be able to create medicines of new generation.

“One of the current priorities is the development of the pharmaceutical cluster,” he said at the meeting with Industry and Trade Minister Viktor Khristenko late on Thursday. “It is necessary to invest into the future. The creation of new generation medicines and new medical technologies is a long and very expensive process. We need to work in this direction as the creation of such medicines is a revolutionary reform and an opportunity to enter new markets.”

Khristenko reiterated that “in late 2010 following the president’s instruction the government adopted a federal program for the pharmaceutical industry development.” “Within the upcoming ten years 188 billion roubles will be injected into the program, of them 122.5 billion roubles – from the federal budget.”

He noted that 154 billion roubles will be earmarked for research and development, thus this lays the groundwork for modernization and innovative development.

Khristenko underlined that according to his estimates, “90 percent of strategic and essential medicines will be produced by domestic companies by 2015.”

In 2010 approaches to the system of state purchasing of medicines for severe disease treatment were changed. Participation of Russian companies in the production of such medicines comprised 9.6 percent as against 0 percent in 2008.

“The market regulation system drastically changed – a new law was adopted and new guidelines on strategic medicines and new preferences for state purchasing from domestic companies appeared,” the minister said. “Over 11 months of 2010 the growth of domestic production totalled 37.7 percent. I think that this share will grow to 25 percent according to the results of 2010. Our target is 50 percent.” Russia’s pharma cos can create new generation medicines - Medvedev

www.itar-tass.com

 Russian President Dmitry Medvedev has expressed confidence that the country’s pharmaceutical companies will be able to create medicines of new generation.

“One of the current priorities is the development of the pharmaceutical cluster,” he said at the meeting with Industry and Trade Minister Viktor Khristenko late on Thursday. “It is necessary to invest into the future. The creation of new generation medicines and new medical technologies is a long and very expensive process. We need to work in this direction as the creation of such medicines is a revolutionary reform and an opportunity to enter new markets.”

Khristenko reiterated that “in late 2010 following the president’s instruction the government adopted a federal program for the pharmaceutical industry development.” “Within the upcoming ten years 188 billion roubles will be injected into the program, of them 122.5 billion roubles – from the federal budget.”

He noted that 154 billion roubles will be earmarked for research and development, thus this lays the groundwork for modernization and innovative development.

Khristenko underlined that according to his estimates, “90 percent of strategic and essential medicines will be produced by domestic companies by 2015.”

In 2010 approaches to the system of state purchasing of medicines for severe disease treatment were changed. Participation of Russian companies in the production of such medicines comprised 9.6 percent as against 0 percent in 2008.

“The market regulation system drastically changed – a new law was adopted and new guidelines on strategic medicines and new preferences for state purchasing from domestic companies appeared,” the minister said. “Over 11 months of 2010 the growth of domestic production totalled 37.7 percent. I think that this share will grow to 25 percent according to the results of 2010. Our target is 50 percent.” Russia’s pharma cos can create new generation medicines - Medvedev

www.itar-tass.com

 Russian President Dmitry Medvedev has expressed confidence that the country’s pharmaceutical companies will be able to create medicines of new generation.

“One of the current priorities is the development of the pharmaceutical cluster,” he said at the meeting with Industry and Trade Minister Viktor Khristenko late on Thursday. “It is necessary to invest into the future. The creation of new generation medicines and new medical technologies is a long and very expensive process. We need to work in this direction as the creation of such medicines is a revolutionary reform and an opportunity to enter new markets.”

Khristenko reiterated that “in late 2010 following the president’s instruction the government adopted a federal program for the pharmaceutical industry development.” “Within the upcoming ten years 188 billion roubles will be injected into the program, of them 122.5 billion roubles – from the federal budget.”

He noted that 154 billion roubles will be earmarked for research and development, thus this lays the groundwork for modernization and innovative development.

Khristenko underlined that according to his estimates, “90 percent of strategic and essential medicines will be produced by domestic companies by 2015.”

In 2010 approaches to the system of state purchasing of medicines for severe disease treatment were changed. Participation of Russian companies in the production of such medicines comprised 9.6 percent as against 0 percent in 2008.

“The market regulation system drastically changed – a new law was adopted and new guidelines on strategic medicines and new preferences for state purchasing from domestic companies appeared,” the minister said. “Over 11 months of 2010 the growth of domestic production totalled 37.7 percent. I think that this share will grow to 25 percent according to the results of 2010. Our target is 50 percent.” Russia’s pharma cos can create new generation medicines - Medvedev

www.itar-tass.com

 Russian President Dmitry Medvedev has expressed confidence that the country’s pharmaceutical companies will be able to create medicines of new generation.

“One of the current priorities is the development of the pharmaceutical cluster,” he said at the meeting with Industry and Trade Minister Viktor Khristenko late on Thursday. “It is necessary to invest into the future. The creation of new generation medicines and new medical technologies is a long and very expensive process. We need to work in this direction as the creation of such medicines is a revolutionary reform and an opportunity to enter new markets.”

Khristenko reiterated that “in late 2010 following the president’s instruction the government adopted a federal program for the pharmaceutical industry development.” “Within the upcoming ten years 188 billion roubles will be injected into the program, of them 122.5 billion roubles – from the federal budget.”

He noted that 154 billion roubles will be earmarked for research and development, thus this lays the groundwork for modernization and innovative development.

Khristenko underlined that according to his estimates, “90 percent of strategic and essential medicines will be produced by domestic companies by 2015.”

In 2010 approaches to the system of state purchasing of medicines for severe disease treatment were changed. Participation of Russian companies in the production of such medicines comprised 9.6 percent as against 0 percent in 2008.

“The market regulation system drastically changed – a new law was adopted and new guidelines on strategic medicines and new preferences for state purchasing from domestic companies appeared,” the minister said. “Over 11 months of 2010 the growth of domestic production totalled 37.7 percent. I think that this share will grow to 25 percent according to the results of 2010. Our target is 50 percent.”

Source:  www.itar-tass.com

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company